For your patient, the right test, an effortless process.
We manage the process together with you, from test selection and sample logistics to reporting and interpretation of results. You focus on the clinical decision; we coordinate the rest.
A service that fits your clinical practice
A broad test portfolio
33 tests, from a 12-gene hereditary panel to a 523-gene comprehensive tumour profile, and from EndoPredict® to whole exome and genome sequencing.
Accredited laboratory
A CAP-accredited partner laboratory, certified to ISO 15189, ISO 9001 and ISO 27001 and licensed by the Dubai Health Authority.
Standards-based reporting
ACMG criteria for germline variants; AMP/ASCO/CAP levels of evidence for somatic variants, with FDA/NCCN references and clinical trial matching.
Sample logistics
Blood samples are taken at the Akasya Partner Clinics; we coordinate the retrieval of FFPE tissue blocks with you and the pathology department.
Interpretation and counselling
We work alongside physicians in reviewing reports and offer optional genetic counselling for your patients.
Family screening
When a hereditary variant is identified, we help you plan targeted testing for family members.
Ordering a test in four steps
- 1Submit a request
Tick “For my patient” on the appointment form and enter the test and your patient's contact details. You can also add a clinical note.
- 2We call you
Together with you, we confirm the test selection, the sample type and, if needed, how the tissue block will be obtained.
- 3Sample and analysis
Your patient's sample is taken, or the tissue sample is obtained, and sent to the accredited laboratory.
- 4The report is sent to you
The report is sent to both you and your patient; if you wish, we can review the results together.
Sample information for oncology tests
Sample type and turnaround time for each test. For detailed requirements, please see the relevant test page.
| Test | Sample | Requirement | Turnaround time |
|---|---|---|---|
| OncoSeq® C 91102 | Blood (EDTA tube) | 2 EDTA tubes of blood or DNA in TE buffer; 2–8°C | 2–4 weeks |
| OncoSeq® S 91103 | Blood (EDTA tube) | 2 EDTA tubes of blood or DNA in TE buffer; 2–8°C | 2–4 weeks |
| OncoSeq® VS 91101 | Blood (EDTA tube) | 2 EDTA tubes of blood or DNA in TE buffer; 2–8°C | 2–4 weeks |
| OncoSeq® X 91104 | Blood (EDTA tube) | 2 EDTA tubes of blood or DNA in TE buffer; 2–8°C | 2–4 weeks |
| CanAct® X Solid CNACT-701 | Paraffin-embedded tumour tissue (FFPE) | FFPE tumour block | 3–4 weeks |
| CanAct® X Liquid CNACT-702 | Blood — cell-free DNA/RNA tube | Cell-free DNA/RNA blood collection tube | 3–4 weeks |
| EndoPredict® 46111 | Paraffin-embedded tumour tissue (FFPE) | FFPE block or 10 µm sections, tumour content ≥30%; cold chain | About 1 week |
| ExoSeq® GI 21229 | Blood (2 × 3 ml EDTA tubes) | 2 × 3 ml blood in EDTA tubes; 2–8 °C | 6 weeks |
| ExoSeq® Onco 21203 | Blood (2 × 3 ml EDTA tubes) | 2 × 3 ml blood in EDTA tubes; 2–8 °C | 6 weeks |
Questions from physicians
Which standards are used in the reports?
Germline variants are classified according to ACMG criteria (ClinVar, Varsome, Franklin). In CanAct® X reports, somatic variants are reported with AMP/ASCO/CAP levels of evidence; treatment recommendations are listed with FDA approval and NCCN guideline references, and relevant clinical trials with their NCT numbers.
How is the tissue block obtained?
Once we receive your request, we contact you to plan from which pathology department, and how, the block or sections will be obtained. EndoPredict® requires 10 µm sections and a tumour content of at least 30%.
Does CanAct® X report HRD?
CanAct® X reports point mutations, indels, CNVs, fusions, MSI and TMB. An HRD score is not part of the product specification; however, variants in BRCA1/2 and other homologous recombination genes are reported.
How can I get pricing information for my patient?
Prices for oncology tests are not listed on the website. When you submit a request or message us on WhatsApp, we will send you current pricing and payment options.
Do you offer institutional partnerships?
To find out about our partnership models for hospitals and clinics, please contact us at info@luegroup.com.tr or by phone.
Your genes are ready to talk.
Send us your request; we will call you, answer your questions and find the day that suits you best, together.